COST
48
-2
HAL
55
-5
EXPD
37
-5
TJX
66
11
CMA
73
-4
AVGO
38
-25
GILD
47
-5
HSY
35
-2
BK
74
-5
CNP
52
2
ROP
38
-10
UNH
38
2
SHW
53
-2
DG
74
-2
CNX
52
-8
PFE
39
-2
NVDA
47
-5
PNC
76
-6
PCG
66
5
RRC
65
12
COST
48
-2
HAL
55
-5
EXPD
37
-5
TJX
66
11
CMA
73
-4
AVGO
38
-25
GILD
47
-5
HSY
35
-2
BK
74
-5
CNP
52
2
ROP
38
-10
UNH
38
2
SHW
53
-2
DG
74
-2
CNX
52
-8
PFE
39
-2
NVDA
47
-5
PNC
76
-6
PCG
66
5
RRC
65
12
Financhill
Back

Fidelity MSCI Financials Index ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Buy
75

FNCL
Fidelity MSCI Financials Index ETF

Last Price:
$78.36
Seasonality Move:
0.52%
Buy
67

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$113.86
Seasonality Move:
-9.01%
Buy
75
Fidelity MSCI Financials Index ETF (FNCL) is a Buy

Is Fidelity MSCI Financials Index ETF a Buy, Sell or Hold?

  • The current Fidelity MSCI Financials Index ETF [FNCL] share price is $78.14. The Score for FNCL is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • FNCL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Rhythm Pharmaceuticals, Inc. (RYTM) is a Buy

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $113.56. The Score for RYTM is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FNCL Stock Price Chart

What is Fidelity MSCI Financials Index ETF's stock price today?

  • The Fidelity MSCI Financials Index ETF share price today is $78.14
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FNCL is experiencing slight selling pressure.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $113.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

FNCL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.81 Buy
Relative Strength Index (14 RSI): 69.26 Buy
Chaikin Money Flow: -5837 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (73.54 - 76.58) Buy
Bollinger Bands (100): (74 - 76.46) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.67 Buy
Relative Strength Index (14 RSI): 59.45 Buy
Chaikin Money Flow: -357754 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (98.81 - 108.61) Buy
Bollinger Bands (100): (93.91 - 107.83) Buy

FNCL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 76.64 Buy
20-day SMA: 75.01 Buy
50-day SMA: 74.9 Buy
200-day SMA: 72.71 Buy
8-day EMA: 76.75 Buy
20-day EMA: 75.73 Buy
50-day EMA: 73.63 Buy
200-day EMA: 46.41 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 107.1 Buy
20-day SMA: 105.06 Buy
50-day SMA: 105.14 Buy
200-day SMA: 81.74 Buy
8-day EMA: 108.55 Buy
20-day EMA: 106.16 Buy
50-day EMA: 103.93 Buy
200-day EMA: 86.65 Buy

Fidelity MSCI Financials Index ETF Earnings Growth & FNCL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.

Fidelity MSCI Financials Index ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):